News

Avicenna Alliance at BMES Conference in Washington- video available!
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.

FDA confirms its investment in modeling and simulation for improving drug development
Scott Gottlieb commissioner of the USA Food & Drug Administration has recently written an article for the FDA Blog “FDA Voice” on the impact of the 21st Century Cures Act, which authorised $6.3 billion in additional funding, part of which is dedicated to research and drug development.

MEP Grossetête to visit NovaDiscovery site
On 7 July 2017 MEP Françoise Grossetête (EPP, France) will visit the new site of Avicenna Member, NovaDiscovery in Lyon.

Boston Scientific joins Avicenna Alliance
As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to its list of members: Boston Scientific.

Meetings at US Senate Buildings
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.

BMES conference – Frontiers in Medical Devices
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.